InsiderClue
← All stocks

Pyxis Oncology, Inc.

PYXS Net buying
CIK 0001782223 #3722 in the set updated 20 Sep 2026
Bought (120 mo)
$17.74M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.53M
$15.92K on a plan · $107.10K straight out of an exercise
Sold at will
$5.41M
6 of 10 sales
Net
+$12.21M
+$12.34M against sales at will

By person

15 insiders · 24 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Cormorant Asset Management, LP entity
Former 10% Owner
$7.20M (1)
—
+$7.20M
1,118,854
1.34%
$3.42M
—
PFIZER INC entity
10% owner
$5.00M (1)
—
+$5.00M
5,952,263
7.14%
$18.21M
+43.8%
Chin Mark
Former Director
$5.00M (1)
$5.32M (1)
−$324.57K
66,831
0.0801%
$204.50K
—
Connealy Pamela Ann
CFO & COO
$229.93K (6)
—
+$229.93K
2,309,436
2.77%
$7.07M
+107.1%
Civik Thomas
CEO & Chairman of the Board
$200.02K (1)
—
+$200.02K
221,886
0.2660%
$678.97K
—
Dupont Jakob
Director
—
$107.10K (1) scheduled
−$107.10K
38,741
0.0464%
$118.55K
—
Cline Darren S
Director
$93.89K (1)
—
+$93.89K
251,405
0.3014%
$769.30K
—
Sullivan Lara
President ,CEO & CMO
—
$81.46K (5)
−$81.46K
2,403,882
2.88%
$7.36M
+704.5%
Wadhane Jitendra
Prin Fin & Acct Officer
$17.87K (3)
—
+$17.87K
512,882
0.6149%
$1.57M
+856.0%
HUMPHREY RACHEL
Director
—
$15.92K (3) scheduled
−$15.92K
81,309
0.0975%
$248.81K
—
Bayer World Investments B.V. entity
Former 10% Owner
—
—
—
2,742,338
3.29%
$8.39M
—
Feingold Jay
Chief Medical Officer
—
—
—
730,345
0.8756%
$2.23M
—
FLAVIN JOHN L
Director
—
—
—
413,015
0.4952%
$1.26M
+144.1%
Lewis-Hall Freda C
Director
—
—
—
241,405
0.2894%
$738.70K
—
Palani Santhosh
Director
—
—
—
6,000
0.0072%
$18.36K
—

Individual transactions

24
Insider
Date
Role
Action
Shares
Price
Amount
Dupont Jakob
30 Jun 2026
Director
Sold after exercise
35,000
$3.06
$107.10K
HUMPHREY RACHEL
21 Apr 2025
Director
Sold on a plan
13,896
$1.03
$14.36K
HUMPHREY RACHEL
17 Apr 2025
Director
Sold on a plan
200
$0.97
$194.00
HUMPHREY RACHEL
14 Apr 2025
Director
Sold on a plan
1,400
$0.97
$1.36K
Connealy Pamela Ann
26 Nov 2024
CFO & COO
Buy indirect
83,400
$1.96
$163.46K
Connealy Pamela Ann
26 Nov 2024
CFO & COO
Buy indirect
5,450
$2.00
$10.90K
Connealy Pamela Ann
28 Sep 2023
CFO and COO
Buy
8,000
$1.87
$14.96K
Connealy Pamela Ann
27 Sep 2023
CFO and COO
Buy
6,426
$1.85
$11.87K
Wadhane Jitendra
27 Sep 2023
Chief Accounting Officer
Buy
2,500
$1.87
$4.68K
Connealy Pamela Ann
25 Sep 2023
CFO and COO
Buy
12,000
$1.67
$20.04K
Wadhane Jitendra
25 Sep 2023
Chief Accounting Officer
Buy
5,000
$1.77
$8.85K
Connealy Pamela Ann
22 Sep 2023
CFO and COO
Buy
5,000
$1.74
$8.70K
Wadhane Jitendra
22 Sep 2023
Chief Accounting Officer
Buy
2,500
$1.74
$4.35K
Sullivan Lara
18 Sep 2023
President and CEO
Sell
8,541
$2.10
$17.94K
Sullivan Lara
14 Sep 2023
President and CEO
Sell
100
$2.25
$225.00
Sullivan Lara
13 Sep 2023
President and CEO
Sell
3,000
$2.27
$6.82K
Sullivan Lara
12 Sep 2023
President and CEO
Sell
4,917
$2.25
$11.07K
Sullivan Lara
11 Sep 2023
President and CEO
Sell
20,000
$2.27
$45.41K
PFIZER INC
17 Mar 2023
10% owner
Buy
1,811,594
$2.76
$5.00M
Chin Mark
21 Apr 2022
Former Director
Sell indirect
1,745,761
$3.05
$5.32M
Cline Darren S
8 Dec 2021
Director
Buy
10,000
$9.39
$93.89K
Civik Thomas
18 Nov 2021
Director
Buy indirect
15,700
$12.74
$200.02K
Cormorant Asset Management, LP
13 Oct 2021
Former 10% Owner
Buy indirect
450,000
$16.00
$7.20M
Chin Mark
13 Oct 2021
Director
Buy indirect
312,500
$16.00
$5.00M

What was left out

Form 4 filings counted 101
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 1
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 10,859,098
Sales filed before the plan box existed 1
History held since 12 Oct 2021